Join us in-person in Milan, Italy for the EASD (European Association for the Study of Diabetes) 2026. Learn more about our involvement in the event below.
Evotec at EASD (European Association for the Study of Diabetes) 2026
Poster Presentation
Genetic Engineering and Validation of Immune-Shielding and Kill-Switch for Safe and Durable iPSC-Based T1D Cell Therapy Without Immunosuppression
Presenter: Elisa Zanfini, Principal Scientist, iPSC Cell Therapy
Scalable, GMP-Compatible Manufacturing of iPSC-Derived, Immune-Shielded Islet-Like Clusters With Long-Term in vivo Efficacy as T1D Cell Therapy
Presenter: Katrin Ridders, Research Associate, iPSC Cell Therapy
